“We are seeing viral persistence in tissues over many years after initial infection and the immune system is not able to completely clear this out. And so now we have to figure out how either we a) can get the immune system to clear this all out, or can we use other modalities - antivirals, monoclonal antibodies, immune-boosting modification, things like that, that will actually help purge these kind of persistent infected cells that we're observing in tissue.”

“We're going to look at our antibody spectrum to do a diagnostic accuracy study. What I expect to find is there'll be groups of patients where some of them have holes around the onset of the of the Long Covid symptoms. “